
Balsillie tapped to help lead Manitoba's new technology task force
Article content
Former BlackBerry Ltd. co-chief executive Jim Balsillie will help spearhead an innovation and productivity task force aimed at setting Manitoba's technology strategy, the government announced this week.
Article content
'(These) efforts will position Manitoba as a leader in 21st-century digital governance and economic competitiveness,' said Mike Moroz, Manitoba's innovation and new technology minister, who will co-chair the task force.
Article content
Article content
'But Donald Trump has laid bare the need for our businesses (provincially) and nationally to have more sovereign control,' Balsillie said.
Article content
That, he added, means controlling the AI, the related intellectual property and the companies that use it.
Article content
The task force is set to meet over the next six months and create a strategic plan that will act as a north star for the province's innovation and productivity efforts.
Article content
Other committee members include Manitoba Chamber of Commerce's Clara Buelow; Gautam Srivastava, a professor of computer science at Brandon University; and Debra Jonasson-Young, the executive director of entrepreneurship at the Asper School of Business.
Article content
Article content
Prime minister Mark Carney recently announced the creation of Canada's first-ever cabinet for AI and digital innovation, appointing former journalist Evan Solomon to the role, signalling the importance of tech for this government.
Article content
Article content
While Balsillie declined to say how much Manitoba would spend on its tech initiatives, the federal government's tech mandate means that 'you're going to see a lot of money on the table,' he said.
Article content
Alignment with Ottawa will be a major part of the group's work, but Balsillie said he is waiting to see how new Prime Minister Mark Carney's government follows through on his promise to transform the country's economy.
Article content
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
31 minutes ago
- Globe and Mail
Onfolio Holdings Inc. Launches Referral Partner Program to Accelerate Adoption of AI Visibility Services
WILMINGTON, Del., June 10, 2025 (GLOBE NEWSWIRE) -- Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTCQB: ONFOP) ('Onfolio' or the 'Company') today announced the official launch of its Referral Partner Program to support the rapid growth of its Generative Engine Optimization (GEO) business. The program offers recurring income and long-term upside to professionals who refer clients to Pace Generative LLC, Onfolio's GEO subsidiary, which helps businesses gain visibility in AI-generated answers from tools like ChatGPT, Gemini, Claude, Grok, and Perplexity. For Onfolio, the program should help to capture the demand and scale revenues significantly faster. Generative Engine Optimization (GEO) is a fast-emerging discipline that positions businesses inside AI-generated responses, rather than simply helping them rank in traditional search engines. When prospective clients ask tools like ChatGPT, 'Who's the best cosmetic surgeon in Miami?' or 'Which estate planning firm in NYC is most reputable?', GEO helps to determine whether a business is mentioned in that real-time answer. 'With the way people now search for trusted services, the brands that show up in AI answers will win the next decade,' said Dominic Wells, CEO of Onfolio. 'Our mission is to ensure that great companies don't get left behind - and our referral partners will be essential to helping us scale that impact.' 'AI is now the first stop for answers,' Wells continued. 'If a company isn't cited, it's not just ranked lower, it's invisible. GEO addresses that. And our referral program allows trusted professionals to help their clients while building a new revenue stream for themselves.' For more information about Pace Generative LLC, visit For more information about our referral program, visit or contact Michael Carwile at partners@ About Onfolio Holdings Inc. Onfolio acquires, operates, and scales a diversified portfolio of digital companies. The Company focuses on businesses with strong cash flows, long-term growth potential, and experienced leadership—or those that can be effectively managed by Onfolio's in-house team. By targeting under-optimized businesses with untapped potential, Onfolio adds value through operational expertise, strategic guidance, and advanced technologies. For more information, visit www. Safe Harbor Statement The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continues," "estimates," "projects," "intends," and similar expressions. Examples of forward-looking statements include, among others, statements we make regarding expected operating results, such as revenue growth and earnings, and strategy for growth and financial results. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing new customer offerings, changes in customer order patterns, changes in customer offering mix, continued success in technological advances and delivering technological innovations, delays due to issues with outsourced service providers, those events and factors described by us in Item 1.A "Risk Factors" in our most recent Form 10-K and Form 10-Q, other risks to which our Company is subject, and various other factors beyond the Company's control. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


Globe and Mail
an hour ago
- Globe and Mail
IBM's Software Segment Growth Picks Up: A Sign of More Upside?
International Business Machines Corporation 's IBM Software segment is increasingly gaining traction with an increasing demand for a focused portfolio that provides end-to-end hybrid cloud and AI capabilities. The segment revenues in the first quarter of 2025 increased to $6.34 billion from $5.9 billion a year ago, driven by growth in Hybrid Platform & Solutions, Red Hat, Automation, Data & AI and Transaction Processing, backed by a strong focus on product innovation. The buyout of California-based software company HashiCorp Inc. for an enterprise value of $6.4 billion has brought powerful synergies across key strategic growth areas of IBM, such as Red Hat, watsonx and IT Automation solutions. HashiCorp's tools, Terraform and Vault, have been integrated with IBM's Red Hat platforms to enhance cloud infrastructure management and hybrid cloud security, including for IBM Z. The addition of the new cutting-edge products has significantly improved IBM Software's ability to help organizations optimize IT spending, reduce cloud costs and boost overall efficiency through automation. With a surge in traditional cloud-native workloads and associated applications, along with a rise in generative AI deployment, there is a radical expansion in the number of cloud workloads that enterprises are currently managing. This has resulted in heterogeneous, dynamic and complex infrastructure strategies, which, in turn, have led firms to undertake a cloud-agnostic and interoperable approach to highly secure multi-cloud management. Our revenue estimate for the segment is pegged at $7.52 billion, indicating year-over-year growth of 11.6% at constant currency. Much of this growth is expected to come from Hybrid Cloud businesses (up 23% to $1.9 billion) and Automation (up 15.4% to $1.87 billion). Other Blue-Chip Tech Firms Focusing on Hybrid Cloud Microsoft Corporation MSFT has doubled down on the cloud computing opportunity. Azure's increased availability in more than 60 announced regions globally has strengthened Microsoft's competitive position in the cloud computing market. Operating through a vast network of global data centers that ensure high availability and reliability for applications, Azure offers seamless access to all the services included in the portal once customers subscribe to it. Subscribers can use these services to create cloud-based resources, such as virtual machines and databases, which can then be assembled into running environments used to host workloads and store data. Inc. AMZN enjoys a dominant position in the cloud-computing market, particularly in the IaaS space, thanks to Amazon Web Services (AWS), which is one of its high-margin-generating businesses. AWS is the world's most comprehensive and broadly adopted on-demand cloud computing platform, offering more than 200 fully featured services from data centers globally. Millions of customers, including the fastest-growing startups, largest enterprises and leading government agencies, are using AWS to lower costs, become more agile and innovate faster. It reportedly offers the widest variety of databases that are purpose-built for different types of applications to enable subscribers to choose the right tool for the job. IBM's Price Performance, Valuation and Estimates IBM has surged 60.7% over the past year compared with no change for the industry. From a valuation standpoint, IBM trades at a forward price-to-sales ratio of 3.74, above the industry. The Zacks Consensus Estimate for IBM's earnings for 2025 has been on the rise over the past 30 days. IBM currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Only $1 to See All Zacks' Buys and Sells We're not kidding. Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone. See Stocks Now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Inc. (AMZN): Free Stock Analysis Report Microsoft Corporation (MSFT): Free Stock Analysis Report This article originally published on Zacks Investment Research (


Globe and Mail
an hour ago
- Globe and Mail
Analysts Say AI Could Add $100B+ to Healthcare—But Most Systems Aren't Ready
Issued on behalf of Avant Technologies Inc. VANCOUVER – News Commentary – A growing chorus of political and academic voices is calling AI the defining force behind the next evolution in healthcare. Former UK Prime Minister Tony Blair recently warned that failing to embrace AI-driven doctors and nurses could leave entire nations behind, while London Business School professor Nicos Savva echoed the sentiment in Forbes, framing AI as essential to future-ready care. Meanwhile, a new Wolters Kluwer report highlights a troubling disconnect: while interest is surging, most healthcare organizations remain unprepared to deploy GenAI tools at scale. Yet even as institutions scramble to catch up, key breakthroughs are already coming from innovators like Avant Technologies, Inc. (OTCQB: AVAI), Palantir Technologies (NASDAQ: PLTR), Astrana Health, Inc. (NASDAQ: ASTH), Tempus AI, Inc. (NASDAQ: TEM), and SoundHound AI, Inc. (NASDAQ: SOUN). Analysts at McKinsey now estimate that generative AI could generate up to $110 billion in annual value across pharma and medical products alone. Statista projects the broader AI healthcare market will surge from $11 billion today to $188 billion by 2030 — a leap that signals just how quickly the landscape is changing. Avant Technologies, Inc. (OTCQB: AVAI) has just taken a major step forward in its evolution from AI incubator to full-stack healthcare innovator. Today, the company announced it had signed a non-binding letter of intent to acquire 100% of Ainnova Tech, its joint venture partner and the developer of the Vision AI diagnostic platform. Prior to the acquisition, the two companies have been operating jointly through Ai-nova Acquisition Corp (AAC), which holds global licensing rights to Ainnova's technology portfolio and serves as the commercialization engine for Vision AI and all future device deployments. 'We believe bringing the two companies together will offer tremendous value for shareholders, it will simplify the process of advancing our technology to market, and it will deliver value to our customers and partners as we promote our technology portfolio globally,' said Vinicio Vargas, CEO at Ainnova and a member of the Board of Directors of AAC. 'We feel the joint venture has been a success and both companies have worked well together toward a common goal, so we believe that we can be even more successful and use our resources more effectively as one company to further AI in healthcare.' Under the proposed agreement, Ainnova would roll all of its outstanding equity into the combined public entity — unifying leadership and eliminating structural complexity ahead of a scheduled FDA pre-submission meeting in July. While final terms of the deal are still being negotiated, both companies say the merger would streamline commercialization and accelerate the rollout of Ainnova's flagship Vision AI technology — a platform already in use across clinical sites in Latin America for the early detection of diabetic retinopathy, cardiovascular disease, and other chronic conditions. The move also signals growing confidence from Avant's leadership as they prepare to bring proprietary hardware into the mix. In parallel with the merger discussions, Avant and Ainnova are entering the final prototyping stage of a low-cost, automated retinal imaging device — marking a potential turning point in the companies' shared push toward AI-powered early diagnostics. The new device is designed to operate hands-free and feed imaging data directly into the Vision AI platform, enabling near-instant risk reports without expensive equipment or trained personnel. The companies say the camera, developed under their joint venture Ai-nova Acquisition Corp. (AAC), is expected to cost a fraction of legacy fundus cameras. By combining affordability with automation, the device could expand screening access across primary care clinics and emerging-market providers that have traditionally been priced out of ophthalmic diagnostics. 'The cost of a fundus camera has always been a barrier to entry in this market,' said Vargas. 'Our low-cost camera, which is a fraction of the cost of currently available cameras on the market, should allow us to not only enter the market, but to capture a large share of the market.' Also in development are additional platform modules, including a patented dementia detection tool that combines a five-minute blood test with AI-trained algorithms. Although that technology remains in evaluation, the core platform continues to expand its reach and functionality — evolving from a retinal-focused application into a broader engine for predictive healthcare. 'Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily,' said Vargas in a previous statement. 'We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem. To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.' As the camera prototype nears completion, Avant is positioning itself for broader market entry. While a launch date has yet to be announced, the integrated platform is designed to reduce diagnostic friction, speed up referrals, and expand access to early-stage health insights — especially in geographies where affordability, not innovation, remains the primary barrier to care. Palantir Technologies (NASDAQ: PLTR) has partnered with TeleTracking Technologies to bring real-time AI-driven insights to hospitals and health systems. 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach,' said Alex Karp, CEO at Palantir. 'Helping to streamline operations allowing for increased focus on providing the best level of care.' By integrating TeleTracking's Operations IQ platform with Palantir's Foundry and AIP tools, the collaboration will enable smarter resource management, predictive forecasting, and near-instant operational decision-making. The combined platform is designed to improve patient flow, reduce staff burden, and drive measurable gains in both care outcomes and financial performance. Astrana Health, Inc. (NASDAQ: ASTH) recently announced a wave of leadership appointments as the company accelerates its national rollout of an AI-driven, value-based care model. The most notable addition is Sherry McBride, a seasoned Medicare Advantage operator who joins as COO to lead integration and execution across Astrana's growing platform. 'We are thrilled to welcome Sherry, along with other recent executive hires and promotions, to the leadership team at a time of immense growth and opportunity for Astrana,' said Brandon Sim, President and CEO of Astrana Health. 'Her deep experience in delegated value-based care will further strengthen our ability to drive consistent, coordinated, high-quality patient outcomes at scale.' Other hires include a new Chief Data and Analytics Officer, Chief Accounting Officer, and Chief People Officer — a signal of Astrana's broader push to deepen capabilities across every operational tier. With a footprint spanning over 12,000 providers and more than a million patients, Astrana is preparing to scale smart, coordinated care on a national level. Tempus AI, Inc. (NASDAQ: TEM) has expanded its generative AI clinical assistant, Tempus One, with direct integration into EHR systems, allowing physicians to query data and streamline workflows in real time. 'As healthcare faces rising costs and growing complexity, no group bears the burden more heavily than physicians and care teams,' said Ryan Fukushima, Chief Operating Officer at Tempus. 'This evolution of Tempus One represents a meaningful shift from a world where clinicians spend countless hours searching for answers and documenting care, to one where AI rapidly connects the dots across fragmented systems to deliver actionable insights in real time.' The platform now includes embedded ASCO guidelines, appointment prep tools, and intelligent note-taking — reducing administrative burden and improving decision-making in oncology and beyond. Tempus is also rolling out its Agent Builder tool to select providers, enabling custom GenAI solutions integrated directly into clinical practice. SoundHound AI, Inc. (NASDAQ: SOUN) has partnered with Allina Health to launch 'Alli,' an AI-powered voice agent designed to streamline patient access and reduce administrative bottlenecks. "One of our key goals is to make sure that we're providing a market-leading patient experience," said David Ingham, DO, Chief Information Officer of Allina Health. "Alli is an extension of our team, and we're excited to have her on board to streamline operations, reduce wait times, and deliver a faster, more seamless experience for our patients." Built on the Amelia conversational AI platform, Alli integrates with Allina's EHR system to authenticate callers, manage appointments, and soon handle tasks like refilling medications or answering non-clinical questions. "Long wait times and administrative complexity can be a huge source of stress for patients," said Michael Anderson, Executive Vice President of Enterprise AI at SoundHound AI. "We are proud to partner with Allina Health on this important digital transformation. The organization is taking a forward-thinking approach by integrating AI to support patients with immediate, personalized assistance." Early results show improved call efficiency and faster response times, enabling staff to focus on complex patient needs. CONTACT: cs@ (250) 999-4849 DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. is a wholly-owned subsidiary of Media Corp. ('BAY') BAY has been not been paid a fee for Avant Technologies Inc. advertising and/or digital media, but the owner(s) of BAY also own Market IQ Media Group, Inc., which has been paid a fee from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of BAY own shares of Avant Technologies Inc. which were purchased in the open market. BAY and all of it's respective employees, owners and affiliates reserve the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by BAY has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through other investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.